Filing Details

Accession Number:
0001214659-25-007625
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-14 17:00:07
Reporting Period:
2025-05-12
Filing Date:
2025-05-14
Accepted Time:
2025-05-14 17:00:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 11411 Southern Highlands Parkway
Suite 240
Las Vegas NV 89141
No No No No
Transaction Summary
Sold: 1,224 shares Avg. Price: $5.06 Total Value: $6,196.35
Number of Shares After Transactions: 1,843 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-05-12 1,213 $5.06 8,260 No 4 S Indirect By Ault Lending, LLC
Common Stock Disposition 2025-05-12 11 $5.28 1,843 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Ault Lending, LLC
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,068 Indirect By Ault Life Sciences, Inc.
Common Stock 61 Indirect By Ault Life Sciences Fund, LLC
Footnotes
  1. The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.0604. The range of sales prices on the transaction date was $5.0461 to $5.237 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price
  2. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
  3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
  4. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.